Back to Search
Start Over
SORAVE: Sorafenib and everolimus for patients with solid tumors and with KRAS mutated NSCLC - results of a phase I study
- Authors :
- Nogova, L.
Mattonet, C.
Gardizi, M.
Scheffler, M.
Bos, M.
Woempner, C.
Toepelt, K.
Heukamp, L.
Suleiman, A.
Frechen, S.
Soergel, F.
Fuhr, U.
Schnell, R.
Katay, I.
Behringer, D.
Geist, T.
Kaminski, B.
Eichstaedt, M.
Tummes, D.
Buettner, R.
Wolf, J.
Nogova, L.
Mattonet, C.
Gardizi, M.
Scheffler, M.
Bos, M.
Woempner, C.
Toepelt, K.
Heukamp, L.
Suleiman, A.
Frechen, S.
Soergel, F.
Fuhr, U.
Schnell, R.
Katay, I.
Behringer, D.
Geist, T.
Kaminski, B.
Eichstaedt, M.
Tummes, D.
Buettner, R.
Wolf, J.
- Publication Year :
- 2014
Details
- Database :
- OAIster
- Notes :
- English
- Publication Type :
- Electronic Resource
- Accession number :
- edsoai.on1247376005
- Document Type :
- Electronic Resource